Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-28 6:01 pm Purchase | 2026-08-18 | 13D | TUHURA BIOSCIENCES INC HURA | James A. Bianco, M.D. | 3,085,519 4.600% | 380,618 (+14.07%) | Filing History |
| 2026-02-17 4:18 pm Purchase | 2025-12-31 | 13G | TUHURA BIOSCIENCES INC HURA | Highbridge Capital Management, LLC | 6,060,608 9.100% | 6,060,608 (New Position) | Filing History |
| 2025-10-31 11:31 am Purchase | 2025-09-30 | 13G | TUHURA BIOSCIENCES INC HURA | VANGUARD GROUP INC | 2,269,666 4.440% | 35,426 (+1.59%) | Filing History |
| 2025-08-14 5:05 pm Sale | 2025-06-12 | 13G | TUHURA BIOSCIENCES INC HURA | KP Biotech Group LLC | 447,232 0.900% | -2,125,350 (-82.62%) | Filing History |
| 2025-08-14 5:01 pm Sale | 2025-06-12 | 13G | TUHURA BIOSCIENCES INC HURA | CA Patel F&F Investments, LLC | 447,232 0.900% | -2,125,350 (-82.62%) | Filing History |
| 2025-07-29 2:49 pm Purchase | 2025-06-30 | 13G | TUHURA BIOSCIENCES INC HURA | VANGUARD GROUP INC | 2,234,240 5.110% | 2,234,240 (New Position) | Filing History |
| 2024-10-25 4:30 pm Purchase | 2024-10-18 | 13G | TUHURA BIOSCIENCES INC HURA | Theofilos Charles Steve | 2,506,321 5.900% | 2,506,321 (New Position) | Filing History |
| 2024-10-25 4:28 pm Purchase | 2024-10-18 | 13G | TUHURA BIOSCIENCES INC HURA | Patel Samir Rashmikant | 2,466,377 5.800% | 2,466,377 (New Position) | Filing History |
| 2024-10-25 4:26 pm Purchase | 2024-10-18 | 13G | TUHURA BIOSCIENCES INC HURA | KP Biotech Group LLC | 2,572,582 6.100% | 2,572,582 (New Position) | Filing History |
| 2024-10-25 4:23 pm Purchase | 2024-10-18 | 13G | TUHURA BIOSCIENCES INC HURA | CA Patel F&F Investments, LLC | 2,572,582 6.100% | 2,572,582 (New Position) | Filing History |
| 2024-10-25 4:20 pm Purchase | 2024-10-18 | 13D | TUHURA BIOSCIENCES INC HURA | Patel Vijay | 12,346,430 26.700% | 12,346,430 (New Position) | Filing History |
| 2024-10-25 4:16 pm Purchase | 2024-10-18 | 13D | TUHURA BIOSCIENCES INC HURA | James A. Bianco, M.D. | 2,704,901 6.400% | 2,704,901 (New Position) | Filing History |
| 2023-02-13 4:29 pm Unchanged | 2022-12-31 | 13G | KINTARA THERAPEUTICS INC N KTRA | Lind Global Fund II LP | 75,472 0.100% | 0 (Unchanged) | Filing History |
| 2022-04-20 5:11 pm Purchase | 2022-04-14 | 13G | KINTARA THERAPEUTICS INC KTRA | Lind Global Fund II LP | 75,472 5.800% | 75,472 (New Position) | Filing History |
| 2022-02-07 1:26 pm Sale | 2021-12-31 | 13G | KINTARA THERAPEUTICS INC KTRA | Pilkiewicz Carolyn | 23,406 2.410% | -11,250 (-32.46%) | Filing History |